Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer-Reference-Cited by-同舟云学术

Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer

Published:2023-05 Issue:5 Volume:165 Page:1682-1693.e3
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Lengel Harry B.,Zheng Junting,Tan Kay See,Liu Corinne C.,Park Bernard J.,Rocco Gaetano,Adusumilli Prasad S.,Molena Daniela,Yu Helena A.,Riely Gregory J.,Bains Manjit S.,Rusch Valerie W.,Kris Mark G.,Chaft Jamie E.,Li Bob T.,Isbell James M.,Jones David R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference53 articles.

1. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance;Lou;J Thorac Cardiovasc Surg,2013

2. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: a propensity-matched analysis;Brandt;J Thorac Cardiovasc Surg,2019

3. Factors associated with distant recurrence following R0 lobectomy for pN0 lung adenocarcinoma;Brandt;J Thorac Cardiovasc Surg,2018

4. Postoperative radiotherapy for surgically resected ypN2 non-small cell lung cancer;Brandt;Ann Thorac Surg,2018

5. Targeted next-generation sequencing analysis for recurrence in early-stage lung adenocarcinoma;Kim;Ann Surg Oncol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant targeted therapy versus targeted combined with chemotherapy for resectable EGFR-mutant non–small cell lung cancer: a retrospective controlled real-world study;Frontiers in Oncology;2024-07-16

2. Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study;Translational Cancer Research;2024-06

3. Analysis of surgical complexity and short-term prognostic indicators in NSCLC patients: neoadjuvant targeted therapy versus neoadjuvant chemoimmunotherapy;Therapeutic Advances in Medical Oncology;2024-01

4. Oncological characteristics of epidermal growth factor receptor–mutated clinical stage IA lung adenocarcinoma with radiologically pure-solid appearance;The Journal of Thoracic and Cardiovascular Surgery;2023-11

5. Commentary: Evolution of the preoperative space: Neoadjuvant targeted therapy in patients with operable non–small cell lung cancer with actionable mutations … Surgeon equipoise?;The Journal of Thoracic and Cardiovascular Surgery;2023-05